Shanghai Institute of Materia Medica Selects Instem’s Genetic Toxicology and...
CONSHOHOCKEN, Pa. Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that the Shanghai Institute of Materia Medica (SIMM) has committed to...
View ArticleGynesonics Raises $43 Million in Equity Financing
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that it has raised $43...
View ArticleReproCELL Announced: Sales Commencement of “ReproNeuro MQ Medium”, a Cell...
YOKOHAMA, Japan This is a notice that we will on August 3rd commence sales of “ReproNeuro MQ Medium”, a cell culture kit which enables the creation of high-functioning nerve cells derived from human...
View ArticleGenoLogics发布 可与Illumina SeqLab搭配使用的Clarity LIMS X
加州雷德伍德城 (美国商业资讯)–GenoLogics今天宣布上市Clarity LIMS X,这是该公司业界领先的实验室信息学平台的一个版本。Clarity LIMS X版面向与Illumina® SeqLab的协同应用进行了优化,可提供群体级基因组学工作流程中的阳性样本追踪、最大化品质和处理能力、缩短处理时间。 2014年上市的HiSeq...
View Articleエリテック、すい臓がんでERY-ASPを検討する第2相試験で肯定的な安全性評価結果を発表
仏リヨン (ビジネスワイヤ) — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「飢餓腫瘍化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック・ファーマ(Paris:ERYP)(ADR:EYRYY)(Euronext Paris – ERYP; OTC US –...
View ArticleArcadia Biosciences宣布2015年第二季度业绩公布日期
加州戴维斯 (美国商业资讯)–农业技术公司Arcadia Biosciences, Inc. (NASDAQ: RKDA)今日宣布,其计划在2015年8月10日市场收盘后公布2015年第二季度业绩。 公司已预定在美国东部时间下午4:30(太平洋时间下午1:30)召开电话会议,讨论第二季度的业绩以及该季度的主要战略成就。 有兴趣的参与者可拔打以下电话号码参加电话会议: 美国免费拔入电话:...
View ArticlePromega 2015 Corporate Responsibility Report Details Long-Term Investment for...
MADISON, Wis. The recently released Promega 2015 Corporate Responsibility Report highlights investment in the future, environmental preservation and contribution to the community. The report...
View ArticleジェノロジックスがIllumina SeqLabの一部としてClarity LIMS Xをリリース
米カリフォルニア州レッドウッドシティ (ビジネスワイヤ)– ジェノロジックスは本日、Clarity LIMS Xの提供を開始したと発表しました。Clarity LIMS Xは、業界有数の当社ラボインフォマティクスプラットフォームの1エディションです。Clarity LIMSのXエディションはIllumina®...
View Article欧洲药品管理局加速评估ixazomib用于复发/难治多发性骨髓瘤
马萨诸塞州剑桥和日本大阪 (美国商业资讯)–武田药品工业株式会社(TSE: 4502)今天宣布,欧洲药品管理局(EMA)人用药品委员会(CHMP)已给予ixazomib加速评估,ixazomib是口服蛋白酶体抑制剂类研究药物,用于治疗复发和/或难治多发性骨髓瘤。EMA对具有重大公共卫生意义、尤其是属于治疗创新的药品给予加速评估。...
View ArticleBioCision to Develop Controlled-Rate Cell Freezing Systems for Cook Regentec...
SAN RAFAEL, Calif. BioCision, LLC today announced that they have entered into an exclusive partnership with Cook Regentec to develop two custom CoolCell® controlled-rate cell freezing systems for...
View Article2015 International Symposium on Human Identification (ISHI) Welcomes 50+...
MADISON, Wis. Join more than 50 experts at the world’s largest conference on DNA analysis for human identification, featuring historic keynote speaker Kirk Bloodsworth, the first person to be...
View ArticleGE Healthcare to invest in enhanced training for over two million health...
WAUKESHA, Wis. & CHALFONT ST. GILES, United Kingdom In developed countries like the U.S., Europe and parts of Asia, healthcare leaders are trying to optimize efficiency, systems integration,...
View ArticleBIO Joins Coalition Cautioning Against Further Restructuring of Japan’s...
WASHINGTON Today BIO joined a coalition of organizations urging the Government of Japan to maintain the established reimbursement pricing structure for pharmaceuticals and medical devices. While the...
View ArticleColonoscopies of the Future: Adjustable-focus Endoscope Helps to Reduce...
WASHINGTON Colonoscopy is a safe and effective medical procedure that’s proven to saves lives. Used for routine cancer screening, it can help identify colon tumors in their early stages. In...
View ArticleKyowa Hakko Kirin and Bristol-Myers Squibb Announce Immuno-Oncology Clinical...
NEW YORK & TOKYO Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151,“Kyowa Hakko Kirin”) and Bristol-Myers Squibb Company (NYSE:BMY, “Bristol-Myers Squibb”) today announced that the companies have entered...
View ArticleDr. Reddy’s Q1 FY16 Financial Results
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) (BSE: 500124) (NSE: DRREDDY) today announced its consolidated financial results for the quarter ended June 30, 2015 under International...
View Article欧州医薬品庁が再発性/難治性多発性骨髄腫患者の治療薬イキサゾミブに迅速審査の指定を与える
米マサチューセッツ州ケンブリッジ & 大阪 (ビジネスワイヤ)–武田薬品工業株式会社(TSE:...
View ArticleBIO、日本における薬価体系のさらなる変更に反対して注意を喚起している組織連合に参加
ワシントン (ビジネスワイヤ) — BIOは本日、医薬品と医療機器で確立された保険収載の薬価体系を維持するよう日本政府に勧める組織連合に加盟しました。...
View ArticleSIRO Clinpharm Announces Chief Operating Officer Dr. Vatsal Shah
MUMBAI, India SIRO Clinpharm, a leading full service Clinical Research Organization, announced the appointment of its new Chief Operating Officer, Dr. Vatsal Shah, who has been with the company for...
View ArticleGynesonics Announces New CPT Code Established for Sonata™ System
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that the American Medical...
View Article